Clinical Trials Browser

Phase 2 × OTHER × Ovarian Neoplasm Epithelial × Clear all

NCT04780945 2026-02-17

FAB

Phase 2 Terminated

Ovarian Neoplasm Epithelial

NCT03509246 2020-01-14

Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients

Phase 2 Unknown

Ovarian Neoplasm Epithelial